| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.5 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.5 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |